市場調查報告書
商品編碼
966745

急性肌肉損傷:流行病學考察 (2030年)

Acute Muscle Injuries - Epidemiology Insight - 2030

出版日期: 按訂單生產 | 出版商: DelveInsight Business Research LLP | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供美國,歐洲5國(德國,西班牙,義大利,法國,英國)以及日本等7個主要市場急性肌肉損傷市場相關詳細說明,提供疾病的背景和概要,未滿足需求,各國的流行病學,治療方法等相關資訊。

目錄

第1章 主要考察

第2章 摘要整理

第3章 急性肌肉損傷:疾病的背景和概要

  • 簡介
  • 徵兆與症狀
  • 病理學
  • 危險因素
  • 診斷

第4章 患者治療過程

第5章 流行病學和患者人口

  • 流行病學的主要調查結果
  • 前提條件與理論的根據:主要7個國家
  • 流行病學方案:主要7個國家
    • 主要7個國家的急性肌肉損傷的流行病學方案
  • 美國的流行病學
    • 美國的急性肌肉損傷的流行病學方案
  • 歐洲5國的流行病學:各國
    • 德國的流行病學
    • 法國的流行病學
    • 義大利的流行病學
    • 西班牙的流行病學
    • 英國的流行病學
  • 日本的流行病學
    • 日本的急性肌肉損傷的流行病學方案

第6章 治療流程,目前治療,及醫療行為

  • 急性肌肉損傷的治療和管理
  • 急性肌肉損傷的治療流程

第7章 KOL的見解

第8章 未滿足需求

第9章 附錄

  • 參考文獻
  • 報告的調查手法

第10章 DelveInsight的服務內容

第11章 免責聲明

第12章 關於DelveInsight

目錄
Product Code: DIEI1020

DelveInsight's 'Acute Muscle Injuries - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Acute Muscle Injuries epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Acute Muscle Injuries Understanding

The DelveInsight Acute Muscle Injuries epidemiology report gives a thorough understanding of the Acute Muscle Injuries by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Acute Muscle Injuries in the US, Europe, and Japan. The report covers the detailed information of the Acute Muscle Injuries epidemiology scenario in seven major countries (US, EU5, and Japan).

Acute Muscle Injuries Epidemiology Perspective by DelveInsight

The Acute Muscle Injuries epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Acute Muscle Injuries epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Acute Muscle Injuries epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Acute Muscle Injuries Detailed Epidemiology Segmentation

The Acute Muscle Injuries epidemiology covered in the report provides historical as well as forecasted Acute Muscle Injuries epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Acute Muscle Injuries report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

  • The Acute Muscle Injuries report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Acute Muscle Injuries Epidemiology Report and Model provide an overview of the risk factors and global trends of Acute Muscle Injuries in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Acute Muscle Injuries in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Acute Muscle Injuries
  • The report provides the segmentation of the Acute Muscle Injuries epidemiology

Report Highlights:

  • 11-Year Forecast of Acute Muscle Injuries epidemiology
  • 7MM Coverage
  • Total Cases of Acute Muscle Injuries
  • Total Cases of Acute Muscle Injuries according to segmentation
  • Diagnosed cases of Acute Muscle Injuries

KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Acute Muscle Injuries ?
  • What are the key findings pertaining to the Acute Muscle Injuries epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Acute Muscle Injuries across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Acute Muscle Injuries ?
  • What are the currently available treatments of Acute Muscle Injuries ?

Reasons to buy:

  • The Acute Muscle Injuries Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Acute Muscle Injuries market
  • Quantify patient populations in the global Acute Muscle Injuries market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Acute Muscle Injuries therapeutics in each of the markets covered
  • Understand the magnitude of Acute Muscle Injuries population by its epidemiology
  • The Acute Muscle Injuries Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Executive Summary of Acute Muscle Injuries

3. Acute Muscle Injuries : Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Sign and Symptoms
  • 3.3. Pathophysiology
  • 3.4. Risk Factors
  • 3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

  • 5.1. Epidemiology Key Findings
  • 5.2. Assumptions and Rationale: 7MM
  • 5.3. Epidemiology Scenario: 7MM
    • 5.3.1. Acute Muscle Injuries Epidemiology Scenario in the 7MM (2017- 2030)
  • 5.4. United States Epidemiology
    • 5.4.1. Acute Muscle Injuries Epidemiology Scenario in the United States (2017- 2030)
  • 5.5. EU-5 Country-wise Epidemiology
    • 5.5.1. Germany Epidemiology
      • 5.5.1.1. Acute Muscle Injuries Epidemiology Scenario in Germany (2017- 2030)
    • 5.5.2. France Epidemiology
      • 5.5.2.1. Acute Muscle Injuries Epidemiology Scenario in France (2017- 2030)
    • 5.5.3. Italy Epidemiology
      • 5.5.3.1. Acute Muscle Injuries Epidemiology Scenario in Italy (2017- 2030)
    • 5.5.4. Spain Epidemiology
      • 5.5.4.1. Acute Muscle Injuries Epidemiology Scenario in Spain (2017- 2030)
    • 5.5.5. United Kingdom Epidemiology
      • 5.5.5.1. Acute Muscle Injuries Epidemiology Scenario in the United Kingdom (2017-2030)
  • 5.6. Japan Epidemiology
    • 5.6.1. Acute Muscle Injuries Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

  • 6.1. Acute Muscle Injuries Treatment and Management
  • 6.2. Acute Muscle Injuries Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

The table of contents is not exhaustive; will be provided in the final report

List of Tables

  • Table 1: Acute Muscle Injuries Epidemiology in 7MM (2017-2030)
  • Table 2: Acute Muscle Injuries Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Table 3: Acute Muscle Injuries Epidemiology in the United States (2017-2030)
  • Table 4: Acute Muscle Injuries Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5: Acute Muscle Injuries Epidemiology in Germany (2017-2030)
  • Table 6: Acute Muscle Injuries Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7: Acute Muscle Injuries Epidemiology in France (2017-2030)
  • Table 8: Acute Muscle Injuries Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9: Acute Muscle Injuries Epidemiology in Italy (2017-2030)
  • Table 10: Acute Muscle Injuries Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11: Acute Muscle Injuries Epidemiology in Spain (2017-2030)
  • Table 12: Acute Muscle Injuries Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13: Acute Muscle Injuries Epidemiology in the United Kingdom (2017-2030)
  • Table 14: Acute Muscle Injuries Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Table 15: Acute Muscle Injuries Epidemiology in Japan (2017-2030)
  • Table 16: Acute Muscle Injuries Diagnosed and Treatable Cases in Japan (2017-2030)

List of Figures

  • Figure 1: Acute Muscle Injuries Epidemiology in 7MM (2017-2030)
  • Figure 2: Acute Muscle Injuries Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Figure 3: Acute Muscle Injuries Epidemiology in the United States (2017-2030)
  • Figure 4: Acute Muscle Injuries Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5: Acute Muscle Injuries Epidemiology in Germany (2017-2030)
  • Figure 6: Acute Muscle Injuries Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7: Acute Muscle Injuries Epidemiology in France (2017-2030)
  • Figure 8: Acute Muscle Injuries Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9: Acute Muscle Injuries Epidemiology in Italy (2017-2030)
  • Figure 10: Acute Muscle Injuries Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11: Acute Muscle Injuries Epidemiology in Spain (2017-2030)
  • Figure 12: Acute Muscle Injuries Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13: Acute Muscle Injuries Epidemiology in the United Kingdom (2017-2030)
  • Figure 14: Acute Muscle Injuries Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Figure 15: Acute Muscle Injuries Epidemiology in Japan (2017-2030)
  • Figure 16: Acute Muscle Injuries Diagnosed and Treatable Cases in Japan (2017-2030)

The table of contents is not exhaustive; will be provided in the final report